海翔药业: 关于首次回购公司股份的公告

Group 1 - The company Zhejiang Haixiang Pharmaceutical Co., Ltd. has approved a share repurchase plan using its own funds, with a total repurchase amount between RMB 150 million and RMB 300 million, and a maximum repurchase price of RMB 7.46 per share [1][2] - The first share repurchase involved buying back 850,000 shares, which represents 0.05% of the company's total share capital, with a total transaction amount of RMB 5,326,664, at prices ranging from RMB 6.24 to RMB 6.29 per share [1][2] - The repurchase plan is in compliance with relevant laws and regulations, and the company will continue to implement the plan based on market conditions within the specified timeframe [2]